Task: Answer the multiple-choice question.
Query: Which drug exhibits a 6.101\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
(a) Cc1c(C(=O)N2CCCC2)oc2c1-c1[nH]ncc1CC2
(b) COc1cc(C(=O)NCCC(=O)NCCN2CCCCCC2)cc(OC)c1OC
(c) N#Cc1c(NC(=O)CN2CCCCC2)sc2c1CCC2
Answer: c. N#Cc1c(NC(=O)CN2CCCCC2)sc2c1CCC2
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
N#Cc1c(NC(=O)CN2CCCCC2)sc2c1CCC2
N#Cc1c(NC(=O)CN2CCCCC2)sc2c1CCC2
N-(3-cyano-5,6-dihydro-4H-cyclopenta[b]thiophen-2-yl)-2-piperidin-1-ylacetamide